Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Liver Neoplasms × toripalimab × Clear all

Phase

Phase 2 2 Phase NA 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Advanced Solid Tumor 9 Solid Tumor 5 Uterine Cervical Neoplasms 4 Nasopharyngeal Carcinoma 4 Carcinoma, Non-Small-Cell Lung 4 Triple Negative Breast Neoplasms 3 Melanoma 3 Carcinoma, Hepatocellular 3 Squamous Cell Carcinoma of Head and Neck 2 Recurrence 2 Neoplasms 2 Locally Advanced or Metastatic Solid Tumors 2 Endometrial Neoplasms 2 Colorectal Neoplasms 2 Advanced Solid Tumors 2 Advanced Lung Cancer 2 Stomach Neoplasms 1 Solid Tumor, Adult 1 Solid Cancer 1 Sarcoma 1 Pyloric Stenosis, Hypertrophic 1 Pancreatic Neoplasms 1 Pancreatic Cancer Metastatic 1 PD-1 1 Ovarian Neoplasms 1 Meningeal Carcinomatosis 1 Lymphoma, Large B-Cell, Diffuse 1 Liver Neoplasms 1 Liposarcoma 1 Head and Neck Squamous Cell Cancer 1

Interventions

Sorafenib 7 Radiosurgery 6 pembrolizumab 4 Oxaliplatin 4 Cryosurgery 4 Radiotherapy, Conformal 3 Ipilimumab 3 Fluorouracil 3 Bevacizumab 3 tremelimumab 2 spartalizumab 2 lenvatinib 2 Nivolumab 2 Leucovorin 2 Everolimus 2 Doxorubicin 2 Cyclophosphamide 2 Capecitabine 2 yttrium chloride 1 vofatamab 1 toripalimab 1 tocilizumab 1 sapanisertib 1 poly ICLC 1 pertuzumab 1 irofulven 1 fluoromisonidazole 1 fludarabine 1 emibetuzumab 1 durvalumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04069949 2019-10-25

STUHCCPVTT

Sichuan University

Phase 1/2 Unknown

Gastrointestinal

Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡